参考文献/References:
［1］WHO.WHO Director-General‘s remarks at the media briefing on 2019-nCoV on 11 February 2020［EB/OL］.（2020-02-11）［2020-02-17］.https://www.who.int/directorgeneral/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020.
［2］China Daily. WHO declares COVID-19 a pandemic［EB/OL］.(2020-03-13)［2020-04-09］.https://www.chinadaily.com.cn/a/202003/13/WS5e6a90f5a31012821727 ea84.html.
［3］新华视点.什么是“三药三方”？［EB/OL］.［2020-03-18］.https://m.gmw.cn/202003/18/content_1301063857.htm.
［4］李可.小青龙汤治急危重症举要［EB/OL］.（201-04-26）［2020-04-09］.https://www.sohu.com/a/136578942_169286.
［5］韩明祖.刘渡舟应用小青龙汤经验［Ｊ］.甘肃中医,2000,13(5)：11.
［6］夏睿明.小青龙汤治寒饮咳嗽［Ｊ］.现代医药卫生,2015,31(11)：1601.
［7］高建军,乔荣跃,张永康.张永康应用小青龙汤治疗干咳经验［Ｊ］.中华中医药杂志(原中国医药学报),2019,34(7)：3072-3073.
［8］景录先.风寒外感干咳少痰者也可用小青龙汤［Ｊ］.北京中医药大学学报,1996,19(6)：61.
［9］马振兴,李云峰.小青龙加石膏汤临床应用体会［Ｊ］.总装备部医学学报,2011,13(3)：166-167.
［10］Jiang F,Deng L,Zhang L,et al.Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19).J Gen Intern Med,2020,35：1545-1549.
［11］Lechien JR,ChiesaEstomba CM,Place S,et al.Clinical and Epidemiological Characteristics of 1,420 European Patients with mild-to-moderate-Coronavirus-Disease-2019.J-InternMed,2020,288(3)：335-344.
［12］Wang D,Hu B,Hu C,et al.Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel CoronavirusInfected Pneumonia in Wuhan,China［J］.JAMA,2020;323(11):1061-1069.
［13］健康报.北京中医医院院长武汉归来,健康报专访实录［EB/OL］.（2020-01-05）［2020-04-09］.http://www.jkb.com.cn/news/industryNews/2020/0125/468 994.html.
［14］仝小林,李修洋,赵林华,等.从“寒湿疫”角度探讨新型冠状病毒肺炎的中医药防治策略［Ｊ］.中医杂志,2020,61(6)：465-470,553.
［15］王凤霞,张云,刘可春.基于《伤寒论》理法方药理论浅谈新冠肺炎防控策略［Ｊ］.山东科学,2020,33(2)：12-16.
［16］红星新闻.中科院院士：“炎症风暴”成新冠重症患者致死原因之一［EB/OL］.（2020-02-15）［2020-04-09］.https://www.sohu.com/a/373282619_617717.
［17］安徽网.中国科大对新冠肺炎“炎症风暴”研究取得若干重要进展［EB/OL］.（2020-02-17）［2020-04-09］.http://www.ahwang.cn/anhui/20200217/1985045.html.
［18］陈倩,王瑶,焦方舟,等.新型冠状病毒肺炎炎症风暴的发生机制及干预策略［Ｊ］.中华传染病杂志,2020,38(3)：185-188.
［19］澎湃新闻.25例新冠肺炎死亡患者临床分析：因肺部黏液过多窒息而亡［EB/OL］.（2020-02-29）［2020-04-09］.https://www.thepaper.cn/newsDetail_forward_6239016.
相似文献/References:
[1]杨璞叶,黄小正,杨明博,等.从病理学角度探讨清肺排毒汤联合克力芝治疗新冠肺炎的优势[J].陕西中医药大学学报,2020,(预出版):024.
Yang Puye,Huang Xiaozheng,Yang Mingbo,et al.Advantages of novel coronavirus pneumonia treated by Qingfei Detox Soup combined with Lopinavir and Ritonavir Tablets from the perspective of pathology[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):024.
[2]魏耕树 朱恩林 王欣 王卓.益气宣痹汤治疗新冠肺炎后肺纤维化倾向可行性探讨[J].陕西中医药大学学报,2020,(预出版):036.
Gengshu Wei,Enlin Zhu,Xin Wang,et al.Feasibility of Yiqi Xuanbi Decoctionin treating pulmonary fibro - sisafter new crown pneumonia[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):036.
[3]赵晓平 昝强 范小璇** 董盛 孙建飞 周振国 杨磊 岳黎明 王建丽 杨志霈.陕西中医药大学附属医院抗击新冠肺炎疫情“4+4”模式**[J].陕西中医药大学学报,2020,(预出版):061.
Xiaoping Zhao,Qiang Zan,Xiaoxuan Fan*,et al.Follow the Pattern of 4+4 to Prevention and Control Novel Coronavirus Pneumonia(NCP) in Affiliated Hospital of Shaanxi University of Chinese Medicine[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):061.
[4]赵晓平 昝强 范小璇 董盛 孙建飞 周振国 杨磊 岳黎明 王建丽 杨志霈.陕西中医药大学附属医院抗击新冠肺炎疫情“4+4”模式[J].陕西中医药大学学报,2020,(02):008.[doi:10.13424/j.cnki.jsctcm.2020.02.003]
Zhao Xiaoping,Zan Qiang,Fan Xiaoxuan,et al.The 4 +4 Pattern to Prevent and Control Coronavirus Disease 2019 in Affiliated Hospital of Shaanxi University of Chinese Medicine[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):008.[doi:10.13424/j.cnki.jsctcm.2020.02.003]
[5]杨璞叶 黄小正 杨明博 张鑫.从病理学角度探讨清肺排毒汤联合克力芝治疗新冠肺炎的优势[J].陕西中医药大学学报,2020,(03):001.[doi:10.13424/j.cnki.jsctcm.2020.03.001]
Yang Puye,Huang Xiaozheng,Yang Mingbo,et al.Advantages of novel coronavirus pneumonia treated by Qingfei Detox Soup combined with Lopinavir and Ritonavir Tablets from the perspective of pathology[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):001.[doi:10.13424/j.cnki.jsctcm.2020.03.001]
[6]魏耕树朱恩林 王欣 王卓.益气宣痹汤治疗新冠肺炎后肺纤维化倾向可行性探讨[J].陕西中医药大学学报,2020,(5):007.[doi:10.13424/j.cnki.jsctcm.2020.05.002]
Wei Gengshu,Zhu Enlin,Wang Xin,et al.Feasibility of Yiqi Xuanbi Decoction in the Treatment of Post - Covid19 Pulmonary Fibrosis[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):007.[doi:10.13424/j.cnki.jsctcm.2020.05.002]
[7]崔晋伟 张晓梅,杨华升 赖宇鑫 刘彧杉 于小林 姜良铎.姜良铎从急性虚损辨治新型冠状病毒肺炎探讨[J].陕西中医药大学学报,2021,44(01):010.[doi:10.13424/j.cnki.jsctcm.2021.01.002]
CUI Jin - wei,ZHANG Xiao - mei,YANG Hua - sheng,et al.Discussion on the Treatment of COVID-19 from the Pespective of Acute Insufficiency Differentiation Syndrome by JIANG Liang-duo[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(04):010.[doi:10.13424/j.cnki.jsctcm.2021.01.002]
[8]康艳 李耀辉** 薛敬东 刘伊莎.基于脏腑相关理论之肺脾相关分析新冠肺炎的病位[J].陕西中医药大学学报,2021,44(03):005.[doi:10.13424/j.cnki.jsctcm.2021.03.002]
[9]曹雪 蒲秀玲 刘小莹 彭红侠 郭团茂 张晓妮.陕西咸阳地区新型冠状病毒肺炎患者中医临床特征分析[J].陕西中医药大学学报,2021,44(04):001.[doi:10.13424/j.cnki.jsctcm.2021.04.001]
CAO Xue PU Xiuling LIU Xiaoying PENG Hongxia GUO Tuanmao ZHANG Xiaoni.Clinical Characteristics of COVID-19 Patientsin Xianyang District of Shaanxi[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(04):001.[doi:10.13424/j.cnki.jsctcm.2021.04.001]
[10]毛娅 崔翔 王晓玲 刘运磊 吴倩张洁.安康地区26例普通型新冠病毒肺炎患者恢复期中医辨治体会[J].陕西中医药大学学报,2021,44(04):005.[doi:10.13424/j.cnki.jsctcm.2021.04.002]
MAO Ya CUI XiangWANG Xiaoling LIU YunleiWU Qian ZHANG Jie.Experience in Treating 26 cases of CommonCOVID-19 Patients in Convalescence in Ankang area[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(04):005.[doi:10.13424/j.cnki.jsctcm.2021.04.002]